Patent details

EP4088720 Title: RIMEGEPANT FOR CGRP RELATED DISORDERS

Basic Information

Publication number:
EP4088720
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP221827561
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RIMEGEPANT FOR CGRP RELATED DISORDERS
French Title of Invention:
RIMEGEPANT POUR TROUBLES LIÉS AU CGRP
German Title of Invention:
RIMEGEPANT FÜR VERBINDUNGEN IM ZUSAMMENHANG MIT CGRP
SPC Number:

Dates

Filing date:
25/03/2019
Grant date:
03/09/2025
EP Publication Date:
16/11/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/09/2025
EP B1 Publication Date:
03/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/03/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/08/2025
 
 

Name:
Pfizer Ireland Pharmaceuticals Unlimited Company
Address:
Operations Support Group Ringaskiddy, Cork, Ireland (IE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/09/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CROOP, Robert
Address:
United States (US)

2

Name:
CORIC, Vladimir
Address:
United States (US)

Priority

1

Priority Number:
201862647794 P
Priority Date:
25/03/2018
Priority Country:
United States (US)

2

Priority Number:
201862664761 P
Priority Date:
30/04/2018
Priority Country:
United States (US)

3

Priority Number:
201862774285 P
Priority Date:
02/12/2018
Priority Country:
United States (US)

4

Priority Number:
201862777180 P
Priority Date:
09/12/2018
Priority Country:
United States (US)

5

Priority Number:
201862777625 P
Priority Date:
10/12/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4545; A61P 25/06; A61K 9/00; A61K 9/20; A61K 9/19; C07D 471/04;

Publication

European Patent Bulletin

Issue number:
202536
Publication date:
03/09/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/01/2026
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
03/09/2025 Power Of Attorney 1
03/09/2025 Outgoing Correspondence 1